David M. Knott Jr’s Centessa Pharmaceuticals CNTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-39,000
Closed -$1.55M 87
2026
Q1
$1.55M Buy
39,000
+35,000
+875% +$895K 0.92% 26
2025
Q4
$100K Buy
+4,000
New +$101K 0.05% 65

David M. Knott Jr's CNTA Position: Q2 2026 in Review

David M. Knott Jr sold out of Centessa Pharmaceuticals (CNTA) in Q2 2026, closing a stake of 39,000 shares — an estimated $1.55M sold.

David M. Knott Jr first reported a position in CNTA in Q4 2025 and held it in 2 quarters. The position peaked at $1.55M in Q1 2026. 0 funds tracked by Wall St. Rank hold CNTA as of Q2 2026.

  • David M. Knott Jr reported no remaining Centessa Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • David M. Knott Jr sold 39,000 Centessa Pharmaceuticals shares in Q2 2026, an estimated $1.55M.
  • David M. Knott Jr first reported a position in Centessa Pharmaceuticals in Q4 2025 and held it in 2 quarters.
  • David M. Knott Jr's Centessa Pharmaceuticals position peaked at $1.55M in Q1 2026.
  • 0 funds tracked by Wall St. Rank held Centessa Pharmaceuticals as of Q2 2026.

Based on David M. Knott Jr's 13F filing for Q2 2026, filed 12 Aug 2026.